Literature DB >> 21719421

Thalidomide and dexamethasone followed by autologous stem cell transplantation for scleromyxoedema.

Reinhard Bos, Esther G M de Waal, Hilde Kuiper, Bouke P C Hazenberg, Edo Vellenga.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21719421     DOI： 10.1093/rheumatology/ker209

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN： 1462-0324            Impact factor:   7.580


× No keyword cloud information.
  4 in total

Review 1.  Cutaneous Manifestations of Scleroderma and Scleroderma-Like Disorders: a Comprehensive Review.

Authors:  Caterina Ferreli; Giulia Gasparini; Aurora Parodi; Emanuele Cozzani; Franco Rongioletti; Laura Atzori
Journal:  Clin Rev Allergy Immunol       Date:  2017-12       Impact factor: 8.667

2.  [Scleromyxedema. A chronic progressive systemic disease].

Authors:  A Kreuter; M Stücker; A G A Kolios; P Altmeyer; K Möllenhoff
Journal:  Z Rheumatol       Date:  2012-08       Impact factor: 1.372

Review 3.  [Scleromyxedema].

Authors:  M Neufeld; C Sunderkötter; R K C Moritz
Journal:  Hautarzt       Date:  2018-11       Impact factor: 0.751

Review 4.  Lichen myxedematosus: a rare group of cutaneous mucinosis.

Authors:  Ramiro Eugenio Cárdenas-Gonzalez; Maira Elizabeth Herz Ruelas; Jorge Ocampo Candiani
Journal:  An Bras Dermatol       Date:  2019-10-17       Impact factor: 1.896
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.